![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC7A14 |
Gene summary for SLC7A14 |
![]() |
Gene information | Species | Human | Gene symbol | SLC7A14 | Gene ID | 57709 |
Gene name | solute carrier family 7 member 14 | |
Gene Alias | PPP1R142 | |
Cytomap | 3q26.2 | |
Gene Type | protein-coding | GO ID | GO:0003333 | UniProtAcc | Q8TBB6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57709 | SLC7A14 | HCC1 | Human | Liver | HCC | 1.38e-10 | 1.55e+00 | 0.5336 |
57709 | SLC7A14 | HCC2 | Human | Liver | HCC | 1.62e-21 | 1.09e+00 | 0.5341 |
57709 | SLC7A14 | HCC5 | Human | Liver | HCC | 2.95e-14 | 1.11e+00 | 0.4932 |
57709 | SLC7A14 | S014 | Human | Liver | HCC | 7.96e-04 | 2.73e-01 | 0.2254 |
57709 | SLC7A14 | S016 | Human | Liver | HCC | 3.81e-08 | 3.58e-01 | 0.2243 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC7A14 | SNV | Missense_Mutation | c.824G>A | p.Gly275Glu | p.G275E | Q8TBB6 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-B5-A11U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
SLC7A14 | SNV | Missense_Mutation | novel | c.2078N>G | p.Tyr693Cys | p.Y693C | Q8TBB6 | protein_coding | deleterious(0.03) | probably_damaging(0.99) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC7A14 | SNV | Missense_Mutation | c.1682N>T | p.Thr561Met | p.T561M | Q8TBB6 | protein_coding | deleterious(0) | probably_damaging(0.94) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SLC7A14 | SNV | Missense_Mutation | novel | c.1088C>T | p.Ala363Val | p.A363V | Q8TBB6 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC7A14 | SNV | Missense_Mutation | c.1682N>T | p.Thr561Met | p.T561M | Q8TBB6 | protein_coding | deleterious(0) | probably_damaging(0.94) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
SLC7A14 | SNV | Missense_Mutation | c.649N>T | p.Leu217Phe | p.L217F | Q8TBB6 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
SLC7A14 | SNV | Missense_Mutation | rs139104563 | c.1534G>A | p.Gly512Ser | p.G512S | Q8TBB6 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-D1-A0ZO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC7A14 | SNV | Missense_Mutation | rs756436577 | c.725N>T | p.Ala242Val | p.A242V | Q8TBB6 | protein_coding | tolerated(0.23) | benign(0.001) | TCGA-D1-A167-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SLC7A14 | SNV | Missense_Mutation | c.893N>G | p.Thr298Arg | p.T298R | Q8TBB6 | protein_coding | deleterious(0.01) | probably_damaging(0.985) | TCGA-D1-A177-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SLC7A14 | SNV | Missense_Mutation | novel | c.181C>T | p.Leu61Phe | p.L61F | Q8TBB6 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |